Trial Profile
Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 May 2014
Price :
$35
*
At a glance
- Drugs Bepotastine (Primary)
- Indications Allergic conjunctivitis
- Focus Registrational; Therapeutic Use
- Sponsors Bausch & Lomb
- 13 May 2014 New trial record
- 23 Mar 2012
- 21 Jan 2009